In recent years, the potential of non-invasive brain stimulation (NIBS) for the therapeutic
effect of post-stroke spasticity has been explored. There are various NIBS methods …

Despite the frequency of spasticity, robust diagnostic criteria and reliable assessment scales
are required. High-quality studies are needed to support the efficacy of current treatments for …

BACKGROUND Sarcopenia, generally described as “aging-related loss of skeletal muscle
mass and function”, can occur secondary to a systemic disease. AIM This project aimed to …

Stroke recovery is a journey. Stroke survivors can face many consequences that may last the
rest of their lives. Assessment of initial impairments allows reasonable prediction of …

Spasticity is a complex and often disabling symptom for patients with upper motor neuron
syndromes. Although spasticity arises from neurological disease, it often cascades into …

Botulinum toxin type A (BoNT-A) is the treatment of choice for focal spasticity, with a
concomitant effect on pain reduction and improvement of quality of life (QoL). Current …

Introduction Muscle synergy is regarded as a motor control strategy deployed by the central
nervous system (CNS). Clarifying the modulation of muscle synergies under different …

Neuromuscular diseases cause abnormal joint movements and drastically alter gait patterns
in patients. The analysis of abnormal gait patterns can provide clinicians with an in-depth …

Objectives The goal of this study was to examine how the administration and dosing of the
anti-serotonergic medication cyproheptadine hydrochloride (HCl) affects involuntary muscle …

With the trend of aging population getting more obvious, stroke has already been a major
public health problem worldwide. As a main disabling motor impairment after stroke …